跳至主要内容
临床试验/NCT06564805
NCT06564805招募中不适用

Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata

Universidad Autonoma de Nuevo Leon1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年8月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
Treatment response

研究概览

简要总结

The efficacy of two intralesional treatment modalities for alopecia areata will be determined. Thirty patients over the age of 6 with the diagnosis of alopecia areata on the scalp, with an extension of less than 50%, will be included. A comparison will be made between the effectiveness of intralesional Triamcinolone (standard first-line treatment) and intralesional Candida albicans antigen, with serial clinical and trichoscopic pictures at follow-up to evaluate the clinical response and associated adverse effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
6 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of alopecia areata
  • SALT score of less than 50% extension
  • Has not received any topical or systemic treatment in the last month
  • Signed informed consent

排除标准

  • Any skin condition on the scalp (infectious, inflammatory or neoplastic) that could modify the clinical of trichoscopic features
  • Pregnancy or breast-feeding
  • Patients in medications that could cause hair loss as side-effects

研究组 & 干预措施

intralesional Triamcinolone

Active Comparator

Triamcinolone acetonide will be administered intralesionally at a concentration of 4 mg/mL. The solution will be injected in 0.1 mL doses, spaced 1 cm apart. The maximum total dose per session will be limited to 3 mL

干预措施: Candida Albicans Antigen Injection (Drug)

Candida albicans antigen

Experimental

Single subcutaneous administration of 0.1 mL of Candida albicans antigen into one of the alopecic patches

干预措施: Candida Albicans Antigen Injection (Drug)

结局指标

主要结局

Treatment response

时间窗: 5 months

porcentage of hair growth determined by SALT score

次要结局

  • Side effects(5 months)

研究者

发起方
Universidad Autonoma de Nuevo Leon
申办方类型
Other
责任方
Principal Investigator
主要研究者

Erika Lizbeth Alba Rojas

Erika Alba Rojas

Universidad Autonoma de Nuevo Leon

研究点 (1)

Loading locations...

相似试验